Healthcare entrepreneurs — particularly those building digital therapeutics and health technology companies — often enter the market with a strong clinical or technical product and a limited understanding of how the managed care system actually works. This is a costly gap. The managed care system controls the majority of healthcare spending in the United States, and understanding its business models, incentive structures, and decision-making processes is essential for any health tech company that wants to achieve meaningful scale.
The Managed Care Ecosystem: A Primer
Managed care is a system of healthcare delivery and financing designed to control costs and improve quality by coordinating care across providers and settings. The core mechanism is the managed care organization (MCO) — a health plan that contracts with employers, government programs (Medicare, Medicaid), or individuals to provide a defined set of health benefits in exchange for a fixed premium.
MCOs manage costs through several mechanisms: network contracting (negotiating discounted rates with providers), utilization management (prior authorization, concurrent review, case management), and increasingly, value-based payment arrangements that shift financial risk to providers in exchange for shared savings or capitated payments.
For health tech companies, the managed care ecosystem presents both an opportunity and a challenge. The opportunity: MCOs are under constant pressure to reduce costs and improve quality metrics, and they are increasingly willing to pay for technology solutions that demonstrably help them do so. The challenge: MCOs are large, complex organizations with long sales cycles, multiple stakeholders, and a strong preference for evidence-based solutions with proven ROI.
Business Model Archetypes for Digital Health Companies
Sell software directly to managed care plans or provider organizations on a subscription basis. Revenue is predictable, but sales cycles are long (12–24 months) and procurement processes are complex. Success requires a clear ROI story tied to cost reduction or quality metric improvement.
Partner with plans or employers under a shared savings or outcomes-based contract. Revenue is tied to demonstrated clinical outcomes (reduced hospitalizations, improved HEDIS scores, lower total cost of care). Higher risk but higher potential reward — and increasingly preferred by sophisticated payers.
Seek coverage as a reimbursable benefit under Medicaid, Medicare, or commercial insurance. Requires FDA clearance (for prescription digital therapeutics), health technology assessment, and formulary or benefit design negotiations with plans. Long path to market but creates durable, recurring revenue.
Sell to self-insured employers as a supplemental benefit. Faster sales cycles than health plans, but smaller contract sizes and higher churn. Best suited for wellness, mental health, and chronic condition management solutions with strong employee engagement metrics.
Build consumer adoption first, then leverage utilization data and clinical outcomes to sell to plans and employers. Requires significant upfront consumer marketing investment but can create a compelling evidence base for B2B sales.
What Managed Care Plans Actually Buy
Understanding what managed care plans are willing to pay for — and why — is the most important strategic insight for any health tech entrepreneur. Plans are not buying technology; they are buying outcomes. Specifically, they are buying solutions that help them achieve three things: reduce medical loss ratio (MLR), improve HEDIS and STAR quality metrics, and manage regulatory and compliance risk.
Solutions that can demonstrate a direct, quantifiable impact on any of these three dimensions have a clear path to plan adoption. Solutions that cannot — regardless of their clinical elegance or technical sophistication — will struggle to find a sustainable business model in the managed care market.
The most common mistake health tech entrepreneurs make is building a product that solves a clinical problem without solving a financial problem for the payer. A digital therapeutic that improves depression outcomes is clinically valuable — but if it cannot demonstrate a reduction in ED visits, inpatient admissions, or total cost of care, it will struggle to command a reimbursable price point from a managed care plan.
Navigating the Medicaid Market
Medicaid is the largest single payer in the United States by enrollment, and California's Medi-Cal program — with over 14 million enrollees — is the largest state Medicaid program in the country. For health tech companies focused on underserved populations, Medicaid is both the most important market and the most challenging to navigate.
CalAIM has created new entry points for health tech companies in the California Medicaid market, particularly through the Enhanced Care Management and Community Supports programs. Companies that can demonstrate value in reducing ECM costs, improving care coordination efficiency, or supporting Community Supports delivery have a growing set of potential customers — managed care plans, lead entities, and CBOs — who are actively looking for technology solutions.